AVANOS MEDICAL, INC.
About AVANOS MEDICAL, INC.
Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $701.2M
- Net income
- -$72.9M
- Total assets
- $1.1B
- Market cap
- $1.2B
- Gross margin
- 55.4%
- Operating margin
- -57.6%
- Net margin
- -57.0%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $687.8M
- Cost of revenue
- $306.5M
- Gross profit
- $381.3M
- Operating expenses
- $777.5M
- Operating income
- -$396.2M
- Income tax
- -$17.0M
- Net income
- -$392.1M
- EPS (basic)
- $-8.53
- EPS (diluted)
- $-8.53
Balance sheet
- Total assets
- $1.2B
- Current assets
- $393.4M
- Total liabilities
- $325.7M
- Current liabilities
- $165.9M
- Shareholders’ equity
- $828.5M
Cash flow
- Operating cash flow
- $100.7M
- Investing cash flow
- -$27.5M
- Financing cash flow
- -$49.1M
- Net cash flow
- $20.0M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $1.2B
- EPS (diluted)
- $-8.53
- Shares outstanding
- 46.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 21, 2014
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $72.9M in FY2025.
- Revenue declined 4% from FY2020 to FY2024.
- Gross margin of 55.4%, net margin -57.0%.
- Trading near its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review AVANOS MEDICAL, INC..
Write a review
News about AVANOS MEDICAL, INC.
News & sentiment via Polygon.io
